Delivery Order SPE2DB22D2211-SPE2DB25FRWPM
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729.00 firm fixed-price delivery order is for the medication Emgality 120 mg/ml pen injector, and has a completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award, valued at $1,729.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Emgality 120 mg/ml pen, with a performance period ending on May 6, 2025. This award is not associated with a set-aside program and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,023.60 Firm Fixed Price delivery order is for the medication Emgality 120 mg/ml Pen ML, with a period of performance through November 15, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,416.16 firm-fixed-price delivery order is for the supply of Emgality 120 mg/ml pen injector medication, with a period of performance through July 12, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,969.14 firm-fixed-price delivery order covers the supply of Emgality 120 mg/ml pen to DLA. The contract has an ultimate completion date of November 29, 2023 and was awarded on November 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award, valued at $1,815.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product Emgality 120 mg/ml Pen ML, with an ultimate completion date of October 13, 2022. The contract type is Firm Fixed Price, and there was no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,377.66, is for the delivery of the prescription drug Emgality 120 mg/ml penml. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,061.75, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical. This single-award IDC, worth up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,593.50 Firm Fixed Price Delivery Order covers the supply of Emgality 120 mg/mL injectable medication, with a period of performance through December 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award, valued at $2,625.74, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of the pharmaceutical product Emgality 120 mg/ml pen. This is a firm-fixed-price delivery order contract with a completion date of May 20, 2024. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a larger Indefinite...